Skip to main content
Clinical Trials/NCT06404008
NCT06404008
Completed
Not Applicable

A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST): A Randomized Pilot Trial

University of Texas at Austin1 site in 1 country20 target enrollmentJuly 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
University of Texas at Austin
Enrollment
20
Locations
1
Primary Endpoint
Acceptability (qualitative)
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with COPD.

Detailed Description

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with chronic obstructive pulmonary disease (COPD). The intervention is based on the breathing techniques of Pranayama. It was developed with patient and stakeholder input and is targeted for individuals with COPD who have moderate levels of stress and symptom burden. The intervention is a 15-minute breathing protocol which will be taught to participants and subsequently evaluated in a clinic setting with surveys, lung function, and cardiac assessments. This intervention will be pre-tested in 6 individuals, revised, and piloted in 30 individuals (15 in intervention group, 15 in control group). This study will answer the question of 1) whether a controlled breath protocol is feasible, acceptable, and safe for patients with COPD and 2) whether any modifications to the intervention are needed for a future multicenter trial to be proposed and conducted after the completion of the pilot trial. We will also 3) obtain sufficient estimates of variability in stress measures to inform statistical planning of a future trial.

Registry
clinicaltrials.gov
Start Date
July 15, 2024
End Date
July 2, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Trisha M. Parekh

Assistant Professor

University of Texas at Austin

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of spirometry confirmed COPD (FEV1/FVC \<0.70 + FEV1\<80%)
  • Perceived Stress Scale \> 13
  • Age \>40 years old
  • Able to read, write, and speak in English
  • Able to attend 1 in person training session and 1 in person trial sessions

Exclusion Criteria

  • Current regular practice of breathing exercises or pranayama
  • No access to internet or telephone
  • Recent hospitalization for COPD exacerbation or any reason in the past 30 days
  • Other primary lung disease (ILD, asthma, bronchiectasis) by self-report or chart review
  • Non-correctable hearing impairment (i.e. hearing impairment despite hearing aids)
  • Severe cognitive impairment

Outcomes

Primary Outcomes

Acceptability (qualitative)

Time Frame: 6 months

Post-intervention semi-structured, in-depth interviews by telephone conducted by study coordinator to explore acceptability, barriers, facilitators, and survey burden

Acceptability (quantitative)

Time Frame: 6 months

Post-intervention survey on intervention acceptability with Likert scale rated 1 to 10; 10 being most acceptable. Overall average score ≥8 of 10 defined as acceptable. Will assess patient reported enjoyment, difficulty, and adherence

Intervention Feasibility

Time Frame: 6 months

IG: Completion of 2 in-person sessions (1 training, 1 trial) along with \>80% of daily individual practice of breathing protocol (15 minute twice daily)

Trial feasibility

Time Frame: 6 months

Rates of screening, enrollment, retention, reasons for exclusion and refusals, and attrition. Attrition goal \<10% throughout study period.

Secondary Outcomes

  • Modified Medical Research Council dyspnea scale(Day 0, Day 8)
  • Mindful Attention Awareness Scale(Day 0, Day 8)
  • Perceived Stress Scale(Day 0, Day 8)

Study Sites (1)

Loading locations...

Similar Trials